Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt (B-VEC)
Source:
Nasdaq GlobeNewswire
/
19 Dec 2023 07:00:00 America/New_York
N/A
Share on,